Wang Yi


Wang Yi

Name: Wang Yi

Speciality: Treating chronic kidney failure, chronic nephritis, lumbago, edema, paruria

Brief Introduction: Professor, Doctor of Medicine, doctoral supervisor. She is an executive member of Specialty Committee of Nephrology in World Federation of Chinese Medicine Societies, vice director of Youth Working Committee of CAIM, vice director of Nephropathy Branch of China Association for the promotion of TCM, standing committee of Nephropathy Branch of China Association of Chinese Medicine. She completed more than 10 projects at various levels. Now she is in charge of 2 national natural funds, 2 projects of Shanghai Science and Technology Committee and 2 local projects. She is also an editorial board member of Chinese Journal of Integrated Traditional and Western Nephrology, and an expert committee member of Shanghai Nephrology Department Clinical Quality Control Center.

She won the honorary titles of “excellent clinical talents of TCM”, “inheritor of academic experience of old and famous Chinese medicine experts”, “Shanghai Phosphor Science Star”, “back-up specialist of Shanghai University of Traditional Chinese Medicine”, “Shanghai May 1st Labour Medal”, “medical ethics pacesetter” She published more than 100 academic papers, and 2 of which were indexed by SCI. She is also the chief editor of kidney disease diagnosis and treatment manual and focus on your kidneys.

Papers published by Doctor Wang Yi

1. The analysis of Characteristics and Related Factors TCM syndrome in 200 cases of Chronic kidney failure

2. Study on TCM Syndromes of Maintenance Peritoneal Dialysis Patients and Analysis of Related Factors

3. Salinomycin Exerts Anticancer Effects on PC-3 Cells and PC-3-Derived Cancer Stem Cells In Vitro and In Vivo.

4. S100A8 Inhibits PDGF-Induced Proliferation of Airway Smooth Muscle Cells Dependent on the Receptor for Advanced Glycation End-Products.

5. A PRISMA-Compliant Meta-Analysis of MDR1 Polymorphisms and Idiopathic Nephrotic Syndrome: Susceptibility and Steroid Responsiveness.

6. KLF 15 Works as an Early Anti-Fibrotic Transcriptional Regulator in Ang II-Induced Renal Fibrosis via Down-Regulation of CTGF Expression.

7. Clinical Study on Yishen Qufeng Shengshi Recipe for Glomerular Proteinuria Patients: A Randomized Controlled Trial.

8. Amputation of the First Metatarsophalangeal Joint Due to a Aiant Qouty Tophi: A case Report.

9. Acquired Gitelman Syndrome in a Primary Sjögren Syndrome Patient with a SLC12A3 Heterozygous Mutation: A Case Report and Literature Review.

10. Comparison of Efficacy and Safety Between Benidipine and Hydrochlorothiazide in Fosinopril-Treated Hypertensive Patients with Chronic Kidney Disease: Protocol for a Randomised Controlled Trial.

Source of papers

1. The Analysis of Characteristics and Related Factors TCM syndrome in 200 Cases of Chronic Kidney Failure

2. Study on TCM Syndromes of Maintenance Peritoneal Dialysis Patients and Analysis of Related Factors

3. Salinomycin Exerts Anticancer Effects on PC-3 Cells and PC-3-Derived Cancer Stem Cells In Vitro and In Vivo.

4. S100A8 Inhibits PDGF-Induced Proliferation of Airway Smooth Muscle Cells Dependent on the Receptor for Advanced Glycation End-Products.

5. A PRISMA-Compliant Meta-Analysis of MDR1 Polymorphisms and Idiopathic Nephrotic Syndrome: Susceptibility and Steroid Responsiveness.

6. KLF 15 Works as an Early Anti-Fibrotic Transcriptional Regulator in Ang II-Induced Renal Fibrosis via Down-Regulation of CTGF Expression.

7. Clinical Study on Yishen Qufeng Shengshi Recipe for Glomerular Proteinuria Patients: A Randomized Controlled Trial.

8. Amputation of the First Metatarsophalangeal Joint Due to a Giant Gouty Tophi: A Case Report.

9. Acquired Gitelman Syndrome in A Primary Sjögren Syndrome Patient with a SLC12A3 Heterozygous Mutation: A Case Report and Literature Review.

10. Comparison of Efficacy and Safety Between Benidipine and Hydrochlorothiazide in Fosinopril-Treated Hypertensive Patients with Chronic Kidney Disease: Protocol for a Randomised Controlled Trial.

Related Article


Contact Us

Leave a message to us